Nabriva Therapeutics plc Uncategorized Contracts & Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement, dated January 31, 2023, by and among Nabriva Therapeutics Ireland Designated Activity Company, MSD International Business GmbH and Merck Sharp & Dohme LLC
Nabriva Therapeutics plc
Pharmaceuticals
NJ
2023
Open Market Sale AgreementSM, dated May 6, 2021, by and between Nabriva Therapeutics plc and Jefferies LLC
Nabriva Therapeutics plc
Pharmaceuticals
NY
2021
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
Nabriva Therapeutics plc
Pharmaceuticals
2021
Description of the Registrants Securities Registered under Section 12 of the Exchange Act
Nabriva Therapeutics plc
Pharmaceuticals
2020
Open Market Sale AgreementSM, dated June 25, 2019, by and between Nabriva Therapeutics plc and Jefferies LLC
Nabriva Therapeutics plc
Pharmaceuticals
NY
2019
Commercial Packaging Agreement by and between Zavante Therapeutics, Inc. and AndersonBrecon Inc., d/b/a PCI of Illinois, dated as of December 26, 2017
Nabriva Therapeutics plc
Pharmaceuticals
IL
2018
Amended and Restated Three-Way Agreement by and between Laboratorios ERN, S.A, Ercros, S.A., and Zavante Therapeutics, Inc., dated as of July 28, 2016
Nabriva Therapeutics plc
Pharmaceuticals
2018